Skip to main content
. 2021 Sep 15;10(9):2430. doi: 10.3390/cells10092430

Table 1.

Baseline characteristics of both groups.

Stage A HF 1
N = 113
Stage B HF
N = 49
p-Value
Age, years 68.35 ± 6.19 69.88 ± 6.53 0.156
Male, n (%) 72 (63.7) 32 (65.3) 1.00
BMI 2, kg/m 2 26.60 ± 3.76 27.21 ± 3.80 0.342
Smoking, n (%) 22 (19.5) 12 (24.5) 0.53
ASCVD 3 risk score, % 24 ± 11.25 27.46 ± 11.83 0.087
Coronary artery disease, n (%) 34 (30.1) 11 (22.4) 0.35
Hypertension, n (%) 93 (82.3) 44 (89.9) 0.343
Diabetes mellitus, n (%) 40 (35.4) 16 (32.7) 0.858
Urine Alb/Cre 4 (mg/g) 67.21 ± 173.22 175.26 ± 379.36 0.084
NT-proBNP 5 (pg/mL) 78.30 ± 87.55 117.35 ± 114.93 0.040
Hs-Tnt 6 (ng/L) 10.37 ± 5.47 12.70 ± 9.67 0.128
HbA1c 7 (%) 6.44 ± 9.85 6.58 ± 1.56 0.549
Creatinine (mg/dL) 1.00 ± 0.27 1.06 ± 0.40 0.287
AST 8 (U/L) 24.79 ± 11.44 30.80 ± 37.52 0.277
ALT 9 (U/L) 29.05 ± 17.13 38.19 ± 66.93 0.351
Sodium (mEq/L) 141.41 ± 1.92 141.65 ± 2.56 0.501
Potassium (mEq/L) 4.33 ± 0.40 4.27 ± 0.41 0.393
Albumin (g/dL) 4.58 ± 0.23 4.52 ± 0.29 0.194
Total bilirubin (mg/dL) 0.68 ± 0.28 0.66 ± 0.25 0.561
Total protein (g/dL) 7.36 ± 0.40 7.31 ± 0.36 0.494
Uric acid (mg/dL) 6.03 ± 1.48 5.73 ± 1.55 0.252
HDL 10 (mg/dL) 51.83 ± 13.4 52.24 ± 15.28 0.863
LDL 11 (mg/dL) 111.71 ± 26.09 111.02 ± 26.66 0.879
Total cholesterol (mg/dL) 178.60 ± 28.71 180 ± 35.05 0.758
Insulin (μIU/mL) 14.29 ± 7.50 13.79 ± 8.67 0.715
Hs-CRP (mg/L) 12 2.69 ± 11.00 2.21 ± 2.30 0.772
Ferritin (ng/mL) 303.39 ± 240.80 280.78 ± 186.70 0.559
Adiponectin (μg/mL) 8.74 ± 8.86 13.13 ± 10.32 0.011
Leptin (ng/mL) 11.47 ± 11.41 10.77 ± 9.65 0.708

1. HF: heart failure; 2 BMI: body mass index; 3 ASCVD: atherosclerotic cardiovascular disease; 4 Alb/Cre: albumin creatinine ratio; 5 NT-proBNP: N-terminal pro b-type natriuretic peptide; 6 Hs-Tnt: high-sensitivity Troponin T; 7 HbA1c: hemoglobin A1c; 8 AST: aspartate aminotransferase; 9 ALT: alanine aminotransferase; 10 HDL: high-density lipoprotein; 11 LDL: low-density lipoprotein; and 12 Hs-CRP: high-sensitivity C-reactive protein.